<DOC>
	<DOCNO>NCT00461409</DOCNO>
	<brief_summary>The purpose study determine correct dose intravenous levetiracetam term new born baby seizure . In addition information safety efficacy collect . This new anticonvulsant drug promise treatment seizure newborn .</brief_summary>
	<brief_title>IV Levetiracetam Treatment Neonatal Seizures : Pharmacokinetic Preliminary Efficacy Safety Study</brief_title>
	<detailed_description>There press need improve treatment seizure neonatal period . The anticonvulsant agent currently use may damage develop brain quite ineffective control seizure neonate . Newborn seizure common ( 1 300 newborn ) associate poor outcome . 20-30 % infant neonatal seizure die , 20-30 % develop epilepsy outside neonatal period 20-40 % develop cerebral palsy and/or mental retardation . Better treatment neonatal seizure could improve outcomes . An intravenous form anti-seizure medication levetiracetam release use adult epilepsy . Experience oral levetiracetam show safe medication , good efficacy stop seizure age group . The intravenous preparation could allow use neonate seizure . Drug handle body different neonate adult . Before use levetiracetam age group need determine correct dose frequency study absorption distribution body ( pharmacokinetic profile ) . This study add-on open label pharmacokinetic preliminary safety study . Twenty-four patient neonatal seizure , still experience clinical electroencephalographic seizure treatment Phenobarbital treat intravenous levetiracetam , serial determination serum levetiracetam level make allow calculation pharmacokinetic parameter . We also collect preliminary safety data . We specifically monitor abnormality heart rate , respiratory rate blood pressure , unexpected death , occurrence hypotonia , sedation , poor feeding , irritability infection . Blood test monitor blood , liver kidney function check baseline , 48 hour completion 7 day treatment . We also collect preliminary descriptive data efficacy levetiracetam stop neonatal seizure .</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Newborns admit seizure UCSD , Children 's Hospital Sharp Mary Birch NICUs San Diego , CA , USA well Auckland City Hospital , Grafton , Auckland NZ : Term infant ( gestational age great equal 37 week &gt; 2460 gram ( max blood study 6mL =3 % ) Postnatal age &lt; 14 day . Received load dose phenobarbital 20mg/kg and/or phenytoin . Ongoing clinical electroencephalographic seizure despite therapy . For parental consent participate study obtain . Serum creatinine great 1.2 enrollment great 2.0 time . Biochemical abnormality hypoglycemia , hypocalcemia treat result seizure cessation . Severe hypoxic ischemic injury likely result imminent death</criteria>
	<gender>All</gender>
	<minimum_age>37 Weeks</minimum_age>
	<maximum_age>42 Weeks</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Neonatal Seizures</keyword>
	<keyword>Treatment</keyword>
	<keyword>Anticonvulsant</keyword>
	<keyword>Levetiracetam</keyword>
</DOC>